Trial Profile
Investigation of the difference among long acting insulin products in type 1 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2021
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Best-Basal-Insulin-Study
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association
- 05 Jun 2015 Results published in the Diabetologia.
- 19 Sep 2014 Primary endpoint (Standard deviation and coefficient of variation of fasting glucose level in the last week of treatment) has been met.